EpiDermE - Epidemiology in Dermatology and Evaluation of therapeutics
Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort

Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort
Thomas Bettuzzi, Hervé Bachelez, Marie Beylot-Barry, Hugo Arlégui, Carle Paul, Manuelle Viguier, Emmanuel Mahé, Nathalie Beneton, Denis Jullien, Marie-Aleth Richard,
Pascal Joly, Florence Tubach, Alain Dupuy, Emilie Sbidian, Olivier Chosidow; PsoBioTeq study group

Acta Derm Venereol. 2022 Mar 8:102:adv00665.
doi: 10.2340/actadv.v101.566.

Retour en haut